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Abstract 
Primary Care Medicine, including Family Practice and Pediatrics, relies on physical 
patient examination skills and relatively simple instruments for diagnostic decision-
making, monitoring, and referral to specialists. Otitis media is one of the most common 
reasons for a visit to the primary care clinic, and represents a significant burden for 
physicians to properly diagnose and treat this pervasive disease. Unfortunately, 
technological advances in other areas of medicine far exceed work being done with 
respect to primary care devices. New advanced diagnostic and quantitative 
technologies and instruments must to be developed to better assist physicians to detect 
disease and quantitatively monitor disease progression or regression. 
This thesis will discuss recent applications of non-invasive optical imaging in the 
middle ear. A clinical study was organized to observe the tympanic membrane of 
patients with normal, acute, and chronic infections in an attempt to identify 
differentiating characteristics of each infection state. Following this work, algorithms 
were developed to identify and quantify middle ear effusions. Lastly, the development of 
a second-generation portable handheld primary care OCT imaging system is described. 
This work is intended to demonstrate the utility of non-invasive optical measurements in 
the middle ear to better diagnose infection in the primary care setting.   
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Chapter 1: Introduction 
 
1.1: Overview  
 
Most if not all patient examinations performed at the primary care office are based 
on qualitative diagnostic parameters. The tools available to primary care physicians are 
limited, and are relatively simplistic when compared to other medical specialties.  New 
advanced diagnostic and quantitative technologies and instruments are needed in the 
outpatient primary care clinic for the early detection of disease, quantitative monitoring 
of disease progression or regression, and for more efficient and evidence-based 
referrals to medical specialists.  
There are clear opportunities to make improvements in disease diagnosis in this 
area. In the ear, it has recently been discovered that there is a strong correlation 
between chronic episodes of otitis media with the presence of middle ear bacterial 
biofilms1. These structures act as reservoirs for antibiotic-resistant bacteria and seed 
recurrent infections. Unfortunately, there are currently no non-invasive means to detect 
and quantify these structures. Furthermore, current generation otoscopes only offer an 
en face view of the tissue surface, whereas structural depth information is what is truly 
needed to assist in the diagnostic process.  
1.2: Scope of Research 
 
This thesis will focus on the quantification of middle ear infection using Optical 
Coherence Tomography (OCT). Current medical protocols to diagnose and treat Otitis 
Media (OM) rely heavily on qualitative aspects of the middle ear, including redness 
(erythema), injection, swelling (inflammation), among others. Using OCT it is possible to 
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observe the middle ear cavity in depth and quantitate thickness changes in the tympanic 
membrane (TM) between infection, the presence of a biofilm, or an effusion. Using 
these quantitative measures, new diagnostic metrics may provide physicians better 
information for improved patient care. Previously, a portable OCT system was 
constructed to observe middle ear pathologies noninvasively in vivo and performed 
several important preliminary studies2,3. In this thesis, the quantification of middle ear 
infection using OCT to differentiate infection states and decorrelation techniques to 
investigate and quantify middle ear effusions will be discussed, as well as the 
development and construction of a second generation primary care imaging system.  
1.3: Goals 
 
Aim 1: Differentiate acute and chronic otitis media 
 To improve the diagnosis and clinical management of OM and better direct the 
continuity of patient care, new quantitative metrics to differentiate acute and chronic OM 
infections are needed. OCT scans of pediatric patients with different stages of OM will 
be investigated, including those with normal, acute, and chronic OM. The quantitative 
data may reveal new diagnostic metrics that physicians can utilize to more accurately 
diagnose OM infections.  
Aim 2: Quantify the properties and characteristics of an effusion 
Middle ear effusions are visible in OCT scans if particulates within the effusion 
are optically scattering. However, the presence and boundary of the effusion is not 
always accurately known. By first positively identifying the effusion, and then 
subsequently quantifying the optical and viscoelastic mechanical properties, new 
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diagnostic markers can be used for diagnosis. The viscosity of an effusion is known to 
be tied to the incidence of further OM infection, and the bacterial load of an infection is 
related to the turbidity of an effusion. Once quantified, these factors may influence the 
focus of future patient care.  
Aim 3: Design and build a second generation PCI system. 
A second generation Primary Care Imaging (PCI) system will be designed to 
improve the quality of the optical imaging system and utilize stable mounting hardware 
to withstand regular use. The imaging and processing speeds will be improved, as well 
as the form factor of the handheld device. These improvements will bring our device 
closer to becoming an integral part of the Primary Care physician’s toolbox. 
1.4: Outline 
 
A literature review of the current state of diagnostic techniques of OM is found in 
Chapter 2, along with supporting information regarding OCT and Biofilms. Chapter 3 
focuses on the results of a recent clinical study performed at Carle Foundation Hospital, 
Urbana, IL, to differentiate acute and chronic OM. Chapter 4 discusses the identification 
and characterization of the optical and mechanical properties of middle ear effusions, 
and Chapter 5 discusses the next generation system development and construction. 
This thesis concludes in Chapter 6, and discusses intended future directions for this 
work.  
 
 
  
4 
 
Chapter 2: Background Information and Literature Review 
2.1: Otitis Media 
Otitis media (OM) is an extremely common infection of the middle ear, affecting 
80% of children before their third birthday1,2. The infection can cause inflammation, 
swelling, and redness in the ear canal, as well as thickening and stiffening of the 
tympanic membrane (TM). Over 80% of children by their third birthday will have 
experienced at least one episode of Acute Otitis Media (AOM) and 40% will have six or 
more recurrences by the age of seven years. Figure 1 details the prevalence of AOM 
worldwide4. 
 
  
Fig. 1: AOM incidence rate estimates for the year 2005 per hundred people, by the 21 
World Health Organization regions. Darker colors indicate a higher prevalence
4
. 
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2.1.1: The otoscope 
 
If suspected, the standard clinical practice to diagnose OM is to inspect the TM 
and observe any physiological changes related to infection5 using an otoscope. An 
otoscope is a simple illumination and magnification device that enables the user to view 
the TM and ear canal. It is a ubiquitous component of any physician’s toolbox. However, 
since its inception, there have been only incremental changes to its design. The concept 
of observing the TM to diagnose infection is thought to have originated in France, where 
an expandable speculum shaped for the ear and nasal cavity was first described in 
1363 by Guy de Chauliac. In 1838, Ignaz Gruber described a similar funnel-shaped 
speculum device. The auriscope, invented by John Brunton in 1862 in England, 
resembles the otoscopes we are more familiar with today. The first ‘pneumatic 
otoscope’ was described in 1864 by E. Siegel of Germany.  This instrument could apply 
differential pressure into the ear canal, while allowing the user to observe the response 
of the TM. Since then, changes to the design have been incremental, including the 
addition of a longer handle, safer and more powerful illumination devices, better optical 
designs for a larger view of the TM, and in modern times, a CCD camera, and a digital 
port to interface with a computer. Figure 2 shows several examples of the evolution of 
this device6-8.  
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2.1.2: Current clinical diagnostic tools 
 
There are currently several techniques available to primary care physicians to 
diagnose OM, but the most commonly used method remains the standard otoscope 
exam. In a typical exam, the attending physician inserts the tip of an otoscope into the 
ear canal to observe and assess the surface of the TM, and if it is sufficiently 
translucent, there may be an opportunity to qualitatively inspect the TM and assess the 
presence of an effusion within the middle ear. By observing the appearance of the TM, 
a decision on the treatment of any suspected infection can be made. However, 
otoscopy is fundamentally limited, owing to the qualitative nature of visual inspection 
and interpretation of the appearance of the TM. This results in a 70% sensitivity and 
Fig. 2: The evolution of the otoscope. (a) Brunton auriscope
6
. (b) Antique German 
otoscope from 1920-1930
7
. (c) A current model Welch allyn otoscope
8
. Not many new 
features have been added since its inception, with the exception of combining or 
improving on existing features.  
a b 
c 
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specificity for diagnosing OM using standard otoscopy9. Other clinical methods, such as 
reflectometry, tympanometry, or middle ear power analysis (MEPA), utilize calibrated 
sound waves to test the response of the eardrum to stimuli. This can be used to detect 
the presence of a middle ear effusion, as the response of the TM changes during 
infection10. However, data collection is dependent on a clear ear canal free of cerumen 
(earwax) and a proper seal11.  
Pneumatic otoscopy is another commonly employed technique, which relies on 
deflection of the TM using changes in pressure in the ear canal. This method has been 
traditionally been viewed as the most accurate technique to diagnose OM. Yet 50% of 
physicians do not utilize pneumatic otoscopy as part of their normal patient exam12, and 
43% of pneumatic otoscope exams are performed or interpreted incorrectly without 
proper training13. It has been speculated that only 10% of physicians utilize pneumatic 
otoscopy on a regular basis. Overall, most all currently available methods used to 
diagnose OM suffer from a qualitative interpretation of the resulting data. 
2.1.3: Clinical standards for diagnosis of OM 
 
The accurate diagnosis of otitis media (OM) lies in navigating the numerous 
confounding and qualitative factors that may present during an exam, including patient 
history and physical exam, prior antibiotic prescription, swelling and/or otalgia of the TM, 
and overall presentation of the infection. During patient examinations, most diagnostic 
parameters are based on physical characteristics of the TM, including but not limited to 
coloration, transparency, injection, and the presence of an effusion.  Otitis media is 
traditionally separated into two distinct diagnoses: acute and chronic/recurrent cases. 
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The recommendations outlined by the American Academy of Pediatricians fully describe 
this diagnostic process and treatment guidelines5.  
Both diagnoses can present with an effusion, an accumulation of liquid behind 
the TM. A middle ear effusion often forms once the Eustachian tube (ET) is blocked. 
Unless the effusion clears on its own, tympanostomy tubes are then frequently needed 
to drain the middle ear cavity and allow air exchange, making it the most commonly 
performed surgical procedure under general anesthesia for young children2. As OM 
infections advance without treatment, severe damage to the mastoid bone and finer 
structures in the middle ear can occur, which can lead to permanent hearing loss. The 
World Health Organization (WHO) estimated that twenty-eight thousand deaths every 
year are attributable to complications of OM, mainly through meningitis and brain 
abscess. This is an unfortunate statistic, as OM is a very preventable source of hearing 
loss and death4. Even in developed world countries, hearing loss caused by OM in 
children leads to severe communication and cognition impairment during adolescent 
development. 
Antibiotics are usually prescribed and effective at clearing the majority of 
infections. However, while antibiotic treatment reduces pain and the incidence of TM 
perforations, 82% of acute OM infections without antibiotic treatment will resolve on 
their own14. Furthermore, when antibiotics are prescribed, they are often ineffective in at 
least 13-19% of cases15. Typically, broad spectrum oral antibiotics are prescribed, with 
some physicians instead opting for ototopical agents. The majority of patients will 
recover and have no further complications.  
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 In rarer cases, such as children with incompletely developed eustachian tubes 
(ET) or in patients with altered ET function, recurrent episodes of OM are common. 
While a healthy ET allows for drainage and air flow in and out of the middle ear, OM 
infections can cause the ET to become constricted or blocked due to swelling or 
inflammation. This inflammation can induce a microenvironment that is favorable for the 
formation of not only an effusion in the middle ear, but also a bacterial biofilm. Although 
antibiotics are prescribed for chronic cases, they are largely ineffective due to the 
thousand-fold increase in antibacterial resistance that biofilms confer to bacteria16. For 
this reason, most physicians are prescribing antibiotics more judiciously in an effort to 
reduce any possible bacterial antibiotic resistance in the future.  
The majority of ear infections are manageable and typically do not cause 
permanent damage to the patient. However, the burden of care associated with OM 
extends beyond the physician’s office. Children miss time from school due to infection 
symptoms and doctors’ visits. Similarly, the primary caregivers suffer a drop in 
productivity at work due to lost time, negatively impacting their respective companies 
and society as a whole. Primary caregivers subsequently lose income from time taken 
off of work, and also to a lesser extent from medical fees from initial and follow-up care, 
as well as any associated antibiotic prescriptions for their children. The associated 
burden is more significant if the child requires surgical intervention to clear the infection. 
On average, this results in hundreds to thousands of dollars in loss of income per 
child17.  
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OM is an infection of the middle ear, which consists of the eardrum or tympanic 
membrane, three small bones often grouped together and named the ossicles, which 
relay sound to the cochlea within the middle ear cavity, and the Eustachian tube, a 
source of drainage and ventilation from and into the middle ear cavity. Each are 
highlighted in Figure 3, which describes and labels major features of the human ear18. 
To visually assess the middle ear, otoscopes are often used to straighten the ear canal 
and provide magnification and illumination of the tympanic membrane, the only easily 
viewable window into the middle ear. Difficulty in diagnosing middle ear conditions is 
mostly due to poor viewing conditions and the qualitative inspection of infection 
symptoms. Diagnosing inner ear disorders and infections is currently not possible non-
invasively. Figure 4 presents several representative image stills of common 
presentations of OM infection19.  
  
Fig. 3: The human ear. OM infections persist in the middle ear cavity, 
easily viewable through the tympanic membrane
18
. The four highlighted 
elements labeled in this figure compose the middle ear.  
  
11 
 
 
Currently, it is challenging for even the most experienced physicians with modern 
versions of the otoscope to extract a correct diagnosis. Physicians could readily utilize 
more precise information regarding fundamental processes of OM infection, especially if 
better models for prescribing antibiotics and providing treatment could be developed. 
There is a clear need to better understand the pathology of OM and more accurately 
quantify the broad range of presentations of this disease. 
  
Fig. 4: Typical presentations of various stages of OM. While these images may be 
representative of the majority of OM pathology, there exist numerous pathologies that 
express qualities from between two stages or a combination of multiple stages
19
.    
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2.2: Biofilms and their role in infection 
Biofilms are known to inhabit commercial and industrial water distribution 
systems20, play essential roles in our environment21, and exist even within our own 
bodies22,23. They can be sources of benefit or a significant disadvantage for each of 
these areas. For example, they play a beneficial role in digestion, but a detrimental role 
as one of the sources of recurrent diseases in humans. The understanding of their role 
in infection, as well as a more basic understanding of their formation and growth, must 
be explored.  
2.2.1: Biofilms in Medicine  
 In general, a biofilm is defined as an aggregate of bacterial microorganisms that 
excrete a matrix of self-produced extracellular polymeric material24. When adhered to 
tissue, biofilms act as a reservoir for bacteria. The bacteria residing in protective 
biofilms are incredibly resistant to antibiotics7, where approximately 48% of chronic 
infections persist after treatment even with topical antibiotics. This is significant, as 
topical antibiotics typically exceed the active dose per area when compared to oral 
antibiotics. It is not surprising, then, that biofilms increase antibiotic resistance by 
approximately 1,000 fold when compared to free floating, planktonic bacteria16. 
 Biofilms that impact medical care are typically those that form on an orthopedic 
implanted devices25, in and on implanted catheters26, in the lungs27, even on surgical 
sutures28,29. In contrast to biofilms in the human gut, these harmful biofilms are not 
naturally present in the body and induce chronic inflammation30 in the patient that 
impedes the healing process31. In health-compromised individuals, the response to a 
biofilm infection can be detrimental during recovery. Detecting the presence of biofilms 
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in humans would help better direct patient care by assisting in the prescription of proper 
drug regimens.  
2.2.2: Biofilm formation and lifecycle 
 
Biofilms are theorized to develop through five observable stages. First, free-
floating planktonic bacteria find and attach to a surface via chemotaxis that has some 
type of macromolecule already adhered, such as proteins, various glycoproteins, or 
immunoglobulins. The planktonic bacteria attach non-specifically at first, but eventually 
irreversibly attach to the surface through a process known as quorum sensing. During 
non-specific attachment, bacteria begin excreting a signaling protein. As the local 
bacterial population increases, the concentration of this signaling protein increases. 
Nearby bacteria sense this signaling protein and eventually reach a threshold 
concentration that triggers a genetic shift to up-regulate virulence factors and the 
secretion of extracellular polymers (EPS)32. Once this EPS matrix is formed, the biofilm 
continues to grow and mature as the bacteria divide within the biofilm and excrete more 
and more EPS. The biofilm survives and proliferates by filtering nutrients from the 
surrounding media, or by breaking down nearby nutrients to fuel further growth. As it 
becomes larger and more mature, it releases fragments of bacteria and EPS that can 
attach downstream or nearby and continue development. This can also cause a 
dangerous blockage if within a vessel, known as a thromboembolism32. Figure 5 
illustrates this growth process33. 
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The non-uniform structure biofilms typically exhibit allows the formation of 
chemical, pH, or oxygen gradients34, which can drastically changes the effectiveness of 
applied antibiotics throughout the biofilm structure35. These gradients can also allow one 
or multiple species of bacteria to proliferate together, even those that prefer 
environments of a different pH or oxygen concentration than the natural state of the host 
or partner bacterium. Furthermore, more superficial levels in the biofilm that are 
exposed to antibiotic treatment confer antibiotic resistance to the rest of the colony in 
deeper levels through horizontal gene transfer36. In addition to these complications, the 
host immune system typically cannot attack the biofilm, due to the ability of the biofilms 
to evade the host immune system25. Macrophages have difficulty encapsulating 
Fig. 5: Five stages of biofilm development. (1) Initial attachment, (2) Irreversible attachment, 
(3) Maturation I, (4) Maturation II, and (5) Dispersion. Each stage of development in the 
diagram is paired with a photomicrograph of a developing P. aeruginosa biofilm. All 
photomicrographs are shown on the same order of magnification
33
. 
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sections of the biofilm due to its sheet-like nature. Even if an immune cell can penetrate 
into the biofilm, it is often unable to successfully phagocytose the bacteria37. Other 
recent work suggests that the immune response actually assists in the formation of a 
biofilm38. It is theorized that the bacteria evolved to form an EPS matrix to stimulate an 
immune response in the host. This persuades immune cells to adhere to surfaces with 
bacteria, where they are utilized as anchor points to drive the growth of the biofilm.   
  It has recently been discovered that biofilms on the TM have a direct correlation 
with effusions that form in the middle ear and chronic OM1,2,39. This is a troubling but 
unsurprising fact, as severe chronic ear infections require surgical intervention to clear 
the infection. The presence of biofilms in the middle ear and their link to chronic OM in 
humans was first established in a chinchilla animal model40, and then later in a seminal 
study in 200641. The complex role that biofilms play in upper respiratory infections in the 
sinuses, middle ear, and throat is not yet well understood, largely due to the fact that 
they are difficult to observe and track in vivo.  
2.3: Optical imaging techniques and systems  
 
As previously discussed, most techniques used to inspect the middle ear for 
infection are qualitative and subject to interpretation of the user. As it is currently used 
today, otoscopy cannot provide quantitative diagnostic information from the TM and 
middle ear. Therefore, a new method is needed that can collect impartial, precise, and 
quantitative data to accurately characterize the middle ear. An invasive measurement 
technique would be impractical to implement for the general population, especially one 
which cannot be performed quickly or safely in an outpatient setting. Primary care 
medicine has not been as fortunate as other specialties and has not received many, if 
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any, technological advancements in recent years. This is in contrast to other medical 
and surgical specialities which have integrated non-invasive imaging techniques that 
have revolutionized diagnostic medicine.  
The first practical demonstration of OCT was first shown at MIT by a team 
headed by James Fujimoto42. Clinical applications in the eye began around 199642 to 
better observe sub-retinal structures for more advanced diagnostics, and have since 
improved and become a standard of care in modern ophthalmologists clinics43. The 
development of this technology occurred alongside the optical telecommunications 
industry. Each mutually benefited from developments in optical technology and 
commercial support, which has led to an emerging optical technologies industry. 
Commercial applications have extended OCT technology to observing external tissue 
sites such as the skin, eye, and teeth, as well as internal tissue sites, such as the 
esophagus and GI tract. Consequently, OCT has the requisite resolution, imaging 
speed, and ease of use required to quickly and regularly observe the middle ear and 
assess the presence of infection in the primary care setting. 
2.3.1: Comparison to other imaging modalities 
The practicality of using a medical imaging modality, such as magnetic 
resonance imaging (MRI), X-ray computed tomography (CT), Ultrasound (US), or OCT 
for investigating injury or infection in a primary care setting has rarely been discussed 
when emergency care is not required. For investigating common diseases, such as OM, 
a rapid scan of the middle ear with no prior preparation is required. Few imaging 
modalities offer this characteristic in a cost effective manner. MRI is a commonly used 
imaging technique, providing excellent soft tissue contrast, but is cost prohibitive to use 
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pervasively for such highly prevalent conditions such as OM. Furthermore, it does not 
have the required resolution to inspect the finer structures of the middle ear cavity. X-
ray CT is excluded outright as it depends of the use of ionizing radiation for image 
reconstruction. More importantly, both MRI and CT are unlikely to be available at most 
primary care offices or clinics unless near or attached to a major hospital, and will 
unlikely be available for use for what is considered non-emergency care.  
Ultrasound is a more obvious choice as a potential solution. It is a cost-effective 
and commonly used imaging technique, and has even been shown to distinguish middle 
ear effusion types44. Still, ultrasound still lacks the resolution needed to observe the TM, 
and may raise concerns regarding damage to finer hearing structures, depending on the 
frequency in use. More importantly, it requires an additional solution or conduction 
media to facilitate signal delivery and collection, which is prohibitive to do within the 
middle ear cavity. Confocal microscopy has more than the required resolution, but 
unfortunately does not exist in a suitable form factor to allow inspection of the middle 
ear. Furthermore, it does not have the required penetration depth to see through and 
behind the TM, and within the middle ear. The lack of a fast and non-invasive, easy to 
use imaging technique may explain why standard otoscopy is still so popular. Figure 6 
describes the resolution and penetration depth of these various methods45. 
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OCT fulfills the need for a non-invasive and non-ionizing imaging technique that 
is capable of resolution in the tens of microns and imaging depths appropriate for the 
middle ear. As an imaging modality, the characteristics OCT inherently provides will 
assist primary care physicians in regular inspection and observation of infection. 
Furthermore, it will enable a better understanding of basic structures and characteristics 
of tissue, and potentially provide new diagnostic criteria for existing pathologies utilizing 
quantitative analysis of collected data. Recently, OCT imaging of the middle ear has 
shown promise that it can enable this quantitative assessment of middle ear biofilms 
and effusions, with the potential to significantly improve antibiotic regimens and clinical 
management of OM infections3.  
 
Fig. 6: A comparison of penetration depth and resolution across 
several imaging modalities. Only OCT has the proper resolution 
depth, ease of use, and noninvasive properties that will allow easy 
and rapid assessment of the middle ear
45
.  
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2.3.2: Principles of OCT 
 
The OCT industry has exploded in popularity in recent years, leading to 
improvements in both hardware and software development. Continuous advancements 
in capability and reductions in cost, size, and shape have brought OCT closer to being a 
mature, well disseminated technology. In general, OCT is an optical depth-ranging 
technique that can resolve the time-of-flight of photons returning from within a medium 
or tissue, enabling fast, high resolution, in vivo imaging of scattering tissue, with an 
imaging depth of about 2 mm. This provides significant advantages for clinical imaging 
systems, especially where the tissue is dynamically changing. OCT is the optical 
analogue to ultrasound imaging, but uses near-infrared light to reconstruct cross-
sectional images of scattering tissue. However, there is currently no detector that can 
sample faster than the speed of light, so optical ranging and subsequent image 
recreation must be accomplished with an interferometer setup. An example setup is 
shown in Figure 7.   
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The interferometer or beam splitter interferes two pulses of light that are coherent 
with one another. The beam from the optical source is split at the fiber coupler or beam 
splitter and half is sent through each arm. One beam is sent through the reference path, 
and on its return to the fiber coupler contains the time delayed pulse of light through a 
known path. The second beam passes through the sample, and on returning to the 
interferometer contains backscattered and reflected light from various structures within 
the sample. If both the sample and reference beams have traveled the same optical 
path length, and a deterministic phase relationship exists between the beams, they are 
temporally coherent with one another. When this coherence condition is met, the beams 
interfere and produce a meaningful signal that can be then reconstructed at our 
detector.   
Fig. 7: A fiber-based spectral-domain OCT system. The broadband light source is 
coupled into a 2 x 2 fiber coupler, which acts as the interferometer and beam 
splitter (BS). A spectrometer detects the light, which allows the reference arm to 
remain static when path length matched with the sample arm, a significant 
improvement over time-domain systems. The interference fringes are detected by 
the digital acquisition unit (DAQ) and processed into A-scans at the computer 
(PC), which can be reconstructed into cross-sectional images with translational 
scanning of the beam over the sample.  
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The detector collects the intensity of an interference pattern (       ( )) from the 
recombined cross-correlation between these two signals: 
       ( )                           √                   
       √                
     
Temporarily ignoring the first two terms, which are DC signal terms, as well as the fourth 
term, the auto-correlation term, the third term is the cross-correlation term containing 
information relevant to the sample of interest. The depth-dependent information of the 
path-length mismatch between the sample and reference arm are contained here. The 
DC terms provide a background signal that is a result of the reflectivity associated in the 
reference and sample arms, and the auto-correlation term is an interference signal from 
two points within the sample. With appropriate processing, it is possible to reconstruct 
the structure of the sample due to the information contained in this third term.  
A spectral-domain OCT system can enable collection of information from all 
depths without adjustment of the reference arm through the use of the Wiener-Khinchin 
theorem. This theorem states that the correlation of two signals is directly related to the 
spectral power density by a Fourier transform (FT). Therefore, if we take an inverse FT 
of the detected spectrum, we can recover the data of interest:  
       ( )     
  (       ( ))    √                   
     
The ability to quickly translate from a power spectrum to a correlation function greatly 
increases imaging speed over a typical time-domain OCT system, which collects 
information from single depths. This speed subsequently enables the imaging of moving 
or dynamic structures. The use of optical fiber and collimators for beam delivery is a key 
addition to enable the use of these types of systems in situations where free space 
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optical beams are not feasible, due to physical constraints or laser safety requirements, 
such as in a healthcare environment.  
The optics in the sample arm of an OCT system plays an important role in 
focusing and collecting backscattered light from the sample of interest. The incident 
sample arm beam is focused into the sample. The numerical aperture of the lens (NA) 
limits the axial and lateral fields-of-view and also determines the lateral or transverse 
resolution:  
         
  
  
  
Lower NA systems will focus the beam less, giving larger depth-of-field, but reducing 
transverse resolution. It is important to note that the lateral and axial resolutions are 
decoupled from one another. The lateral resolution is dependent on the objective lens 
used, whereas the axial resolution is dependent on the coherence length of the light 
source: 
        
    ( )
  
  
 
  
  
From a medical imaging perspective, the imaging depth of an OCT system in the 
human body is highly dependent on the incident power of the light source on the tissue, 
the order of wavelengths used, and the resolution of the spectrometer. Furthermore, 
each component in tissue absorbs and scatters light to a different degree, which will 
lead to local interactions with the light through scattering, as well as overall attenuation 
of light propagation through absorption.  
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Different tissues will have different scattering and absorptive optical properties, 
which also can affect imaging depth. Figure 8 plots the optical absorption coefficient 
across a wide range of wavelengths in the human body46: 
   
  
  
  
  
  
  
  
  
  
  
 
The decrease in the absorption coefficient near the 800 nm range is commonly 
referred to as the diagnostic or biological window, which is situated near the red/near 
infra-red (700 nm ~1300 nm) spectrum. OCT utilizes light sources in this range to image 
deep into tissue. The ANSI safety standards47 detail the maximum permissible exposure 
of optical radiation to prevent thermal damage to tissue, limiting the potential optical 
power used to image tissue.  
Fig. 8: Absorption coefficient versus wavelength for water, 
melanin, and oxygenated hemoglobin. Near 800 nm, there exists 
the “biological window”, where light propagation in tissue is 
limited by scattering rather than absorption. Using OCT, this 
allows deep imaging into tissue
46
.  
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Image quality is dependent on the SNR of an OCT system, which can be 
measured by setting up a mirror as the sample at the focus of the objective, 
representing a perfect reflector:   
     
                            
   
 
Where   is the responsivity of the spectrometer, a coefficient that measures the 
efficiency of the conversion of optical to electronic signal,            is the reflectivity of 
the OCT system’s reference arm,         is the mirror reflectivity at the sample arm, 
        is the power incident upon the sample, and   is the integration time of the 
spectrometer.  
2.3.3: Imaging systems 
 
 The first-generation primary care imaging system was one of the first systems to 
integrate OCT and a CCD camera into a probe-like form factor. This gives it the ability 
to image the tissue of interest by providing a wide field en face view of the tissue with 
the CCD camera and a high resolution cross-sectional depth scan of the tissue using 
OCT. This system has already produced excellent results, first by strengthening the link 
between chronic OM and the presence of a biofilm2, as well as providing possible new 
screening practices for diabetic retinopathy48. 
The first-generation PCI system, which uses spectral domain OCT, employs a 
traditional Michelson interferometer configuration with a super luminescent diode source 
(Superlum, IE) centered at 830 nm with a 70 nm bandwidth. This generates images with 
approximately ~4 µm axial resolution and ~15 µm transverse resolution in tissue. The 
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handheld probe houses a Microelectromechanical System (MEMS) scan mirror 
(Advanced MEMS, Ca) and an interchangeable lens mount for imaging various tissue 
sites common in primary care medicine (ear, eye, nose, skin, etc). In the reference arm, 
two separate optical paths were constructed, one for retinal imaging, which takes into 
account the added dispersion compensation needed for imaging through the vitreous 
and anterior chamber of the eye, and a second for shallower tissue sites, such as the 
ear and skin. B-mode OCT images can be displayed as fast as 70 frames/sec  
(each B-mode has 1000 A-scans). The handheld probe has dimensions of  
5 cm × 10 cm × 12 cm (depth x width x height). The entire optical system and computer 
are contained in a portable medical cart (66 cm x 50 cm x 94 cm, depth x width x height) 
allowing for easy transport to and within medical offices. Figure 9 shows a schematic 
and image of this system.   
 
Fig. 9: First-generation PCI system schematic. Detailed layouts of the optical system and handheld 
scanner are shown. The optical setup, including the spectrometer and reference optical path, is 
completely self-contained in a small portable medical cart. The handheld unit incorporates the 
MEMS based scanning element, integrated LCD, and interchangeable tips (ear shown) for different 
tissue sites.      
  
26 
 
 
2.3.4: OCT imaging in the middle ear 
OCT has been widely used in previous studies to investigate and observe the 
structure and dynamics of the ear. The cochlear response to changes in sound pressure 
in the middle ear was investigated in guinea pigs49, and a 3-D model of the murine 
cochlea has been reconstructed50, both taken in vivo. Previous studies in humans have 
largely been restricted to ex vivo studies, due to the technical difficulties of imaging the 
ear in vivo, including developing an appropriate beam-delivery system. A preliminary 
study investigated the feasibility of differentiating gross structure through the ear canal 
of an ex vivo middle ear51. Another study investigated the topographical thickness of the 
entire TM in several excised ex vivo samples52. Recently, several patients with 
cholesteatoma were imaged in vivo during middle ear surgery to better understand 
composition and structure, and to better differentiate from healthy mucosal tissue53.  
The continued focus in the middle ear is driven by the previous body of work 
using the non-invasive imaging capabilities of OCT to investigate middle ear infection.  
In vitro biofilm structures within a flow cell were first examined to understand their 
appearance and structure in OCT imaging54. Subsequently, OM was induced in a rat 
model55 that showed visible biofilm-like structures affixed to the TM in OCT, which was 
directly correlated to the biofilms present in histology1. Differentiation between the TMs 
of normal rats and those with induced middle-ear infections was possible with OCT due 
to the presence of this biofilm1.  The continuation of this work in human subjects 
focused on OCT imaging of adult subjects with normal ears and with chronic OM. In all 
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subjects with chronic OM, an obvious biofilm-like structure was present and affixed to 
the TM within the middle ear2.  
These structures affixed to the TM were previously recognized as biofilms by 
direct invasive sampling and identification in previous studies of OM infection in 
chinchillas40 and in children taken prior to tympanostomy tube placement41.  Identifying 
the presence of a middle-ear biofilm with OCT is further supported by direct correlation 
between OCT imaging and histology in a pre-clinical animal model1, and in clinical 
studies in human subjects2. Collectively, this prior work firmly established the link 
between chronic OM and biofilms in the middle ear. It demonstrates that a non-invasive, 
real-time OCT image of the TM can be utilized to assess for the presence of a biofilm 
that may develop behind the TM and within the middle-ear. The work presented in 
Chapters 3 will describe new results from the investigation of middle ear infection using 
OCT in the primary care setting to evaluate if image-based biomarkers can be used to 
differentiate different stages of OM.    
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Chapter 3: Differentiating Acute and Chronic Otitis Media 
3.1: Introduction and Motivation 
The current standards for the diagnosis of OM relies on qualitative diagnostic 
factors, typically assessed through patient history and physical exam, prior antibiotic 
prescription, otalgia (ear pain), and overall presentation of infection5. The middle ear is 
examined for changes in coloration, transparency, injection, and the presence of an 
effusion. The proper collection and interpretation of these qualitative parameters varies 
not only with illumination and observation, but also with the experience of the 
physician5. Due to this variability, a wide range of interpretations and diagnoses result, 
even amongst experienced physicians. The resulting sensitivity and specificity for 
diagnosing OM using a traditional otoscope exam has been reported to be 70%12.  
Physicians have several other techniques available to diagnose OM and OM-
related infections non-invasively. Unfortunately, these methods have an accuracy 
similar to otoscope exams11, and are typically recommended to be used alongside a 
typical otoscope for diagnosis. Pneumatic otoscopy measures the stiffness of the TM, 
which is a direct indicator of infection and can assess the presence of a middle ear 
effusion through modulation of pressure within the ear canal. The use of pneumatic 
otoscopy increases the sensitivity by 12% and the specificity by 18% of diagnosis when 
used alongside a traditional otoscope exam12. However, 25 - 50% of physicians do not 
utilize pneumatic otoscopy as part of their normal patient exam, and 43% of pneumatic 
exams are performed or interpreted incorrectly without proper training13. Tympanometry 
and reflectometry are two other methods developed to quantify and standardize 
pneumatic otoscopy. However, these methods are inaccurate when sufficient cerumen 
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within the ear canal is not removed and a proper seal is not attained. This data must 
then be interpreted correctly, which can lead to further inaccuracies. Overall, 
reflectometry has a sensitivity of 63.6% and specificity of 79.7 %, whereas 
tympanometry is characterized as having a sensitivity of 86.9% and a specificity of 
71.7%11. MEPA is another emerging acoustic measurement technique. While no direct 
comparison to other diagnostic methods have been performed, MEPA shows potential 
for an accurate analysis of middle ear infection56. In a promising preliminary study,  
1250 Hz MEPA was found to have the greatest sensitivity and specificity of 95% and 
96% for diagnosing middle ear effusions57. 
Improper estimation of the extent of infection may result in an inadequate 
treatment strategy, likely resulting in additional return visits to the primary care office 
and an increased likelihood for progression to a recurrent or chronic infection. Existing 
infections can withstand the first rounds of antibiotic treatment, having already 
surpassed the efficacy of these drugs. In these more severe cases, it is possible that for 
the infection to resolve, tympanostomy tube placement is required, as the bacteria have 
conferred antibiotic resistance to resist further antibiotic treatment protocols. 
Conversely, an over-aggressive diagnosis leads to the unnecessary prescription of 
antibiotics, which reduces the effectiveness of the antibiotic over time in the general 
population and results in an inefficient use of healthcare resources58. The difficulty in 
treating OM leads to the high prevalence of myringotomy procedures, which is one of 
the most commonly performed surgical procedures under general anesthesia for young 
children59. The prevalence of OM leads to high direct and indirect healthcare costs 
estimated at around $3 billion nationwide60.  
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The aforementioned link between the presence of middle ear biofilms and 
recurrent otitis media infections is becoming clearer. As previously described in  
Section 2.2.2, recent research has shown a biofilm is established in the middle ear in 
chronic OM. More importantly, physician awareness and attitude about biofilms 
populating the middle ear has changed to reflect this recent work. The virulent 
properties of biofilms correlate well with the qualities of this persistent infection. 
Unfortunately, in the 2013 guidelines set forth by the American Academy of Pediatrics, 
the diagnosis and management of OM still relies mainly upon qualitative factors5. There 
is no mention of a biofilm influencing the diagnosis OM. However, this may be simply 
because there is no reliable tool to accurately detect middle ear biofilms, and no large-
scale clinical study to solidify an effective and appropriate treatment to recommend.  
In this chapter, a handheld OCT imaging system, capable of non-invasively 
acquiring real-time images of the human TM in vivo3,48, is used to investigate 
morphological changes in the TM in normal pediatric subjects and subjects with 
clinically diagnosed acute and chronic OM. The presence of a middle-ear biofilm and 
the thickness of the TM will be examined as new screening and diagnostic metrics to 
differentiate normal, acute, and chronic infection states. 
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3.2: Materials and Methods  
This study observes the outpatient pediatric population of Champaign-Urbana, 
Illinois visiting Carle Foundation Hospital at the otolaryngology specialist clinic or the 
pediatric primary care clinic. In total, 34 subjects were recruited for this study, consisting 
of 13 normal presentations of the middle ear, 12 acute, and 9 chronic OM cases. 
Normal, acute, and chronic OM infections were classified based on the clinical 
diagnosis of the attending physician after a thorough physical and otoscopic 
examination.  
Participation in this study was voluntary, with proper consents acquired from all 
imaging participants following University of Illinois and Carle Foundation Hospital 
Institutional Review Board protocols. All collected data was de-identified of personal 
health information. Participants were sorted into one of the three subgroups (normal, 
acute OM, chronic OM) based on the clinical presentation of the infection as taken from 
the physician’s evaluation, following the recommendations for accurate diagnosis as 
outlined by the American Academy of Pediatricians5. There were no gender restrictions, 
but participant’s age was restricted to individuals younger than 18 years old to ensure 
focus on the pediatric population. Subjects were similarly excluded from this study if 
their disposition and/or discomfort prevented imaging with the portable system.  
The portable system used in this study is fully described in Section 2.3.3. Data 
was acquired following the IRB-approved protocol, and was performed once all regularly 
scheduled medical examinations were completed. This served not only to prevent any 
interruption or deviation in patient care, but also provided the physician an opportunity 
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to formulate an unbiased diagnostic opinion based solely on following the current gold 
standard for care. Examination by the portable system added no more than five minutes 
to the exam time. Higher-resolution color surface photos of each TM were collected with 
a commercial digital video otoscope for documentation of the physician’s diagnostic 
criteria. 
To calculate an accurate thickness value, three representative locations across 
the TM were selected at random to ensure an accurate representation of each ear. The 
thickness values were calculated by taking an average thickness from these three 
positions in each image, providing a measure of average optical thickness of each ear. 
Optical thickness in a tissue is equivalent to the physical distance multiplied by the 
index of refraction of the tissue. To convert from optical distance to a physical measure 
of TM thickness, the value is divided by the refractive index of the tissue (n=1.44). This 
has been shown to be the average index of refraction across the TM in humans in  
ex vivo samples52. If the TM was angled in the image, its geometry was accounted for in 
the thickness measurements. 
To investigate the statistical significance of this study, a Welch’s t-test was used 
to compare the measured TM thickness values between infection groups. A traditional 
Student’s t-test could not be used, since it is not known if each TM thickness group has 
equal variance. Each pairing between infection groups was considered by comparing 
the p-value of normal-acute, acute-chronic, and normal-chronic statistics. R©, a 
statistical computational software package, was used to facilitate these calculations, 
which were later manually verified. 
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3.3: Results and Discussion 
Figure 10 displays representative OCT data from the study, highlighting normal 
ear findings, acute OM, and chronic OM pathologies, along with representative 
otoscopic TM video still images. Representative cross-sectional OCT images  
(Figures 10a-c) and video still surface images (Figures 10d-f) emphasize the different 
features corresponding to different pathologies encountered during imaging. Figure 10a 
shows a cross-sectional scan of a normal TM with a strong OCT signal and a thickness 
of approximately 100 microns. Figure 10d shows a video still image of a normal, healthy 
TM. Figure 10b shows a cross-sectional scan of an acute TM with increased thickness 
when compared to the normal case, which is most likely due to inflammation. Acute 
tympanic membranes seem to exhibit lower optical scattering than other states.  
Figure 10e shows a video image of an acute TM, which is bulging, erythematous and 
red. Figure 10c shows a cross-sectional OCT image of a TM (yellow line) from a subject 
with chronic OM. The TM itself has essentially returned to normal thickness and 
brightness, but has a thick accompanying biofilm (blue line/arrows). Figure 10f shows a 
video image of a chronic ear infection with effusion.  
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Table 1 presents subjects in each infection group, with the corresponding clinical 
history and experimentally determined TM thickness. In the chronic OM group, the TM 
thickness has been separated into overall thickness and TM-only thickness to better 
represent the differences between the biofilm and TM. Fig. 11a illustrates the thickness 
distribution of the three pathologic groups, with the chronic OM group separated into 
TM-only thickness and biofilm thickness, with the composite represents total thickness. 
There is a clear trend of increasing overall thickness when observing normal to chronic 
infections. Mean and standard deviation values for each group (normal, acute, chronic, 
and chronic TM-only) are displayed in Fig. 11b.  
Fig. 10: Representative cross-sectional depth-resolved OCT images: (a) normal, (b) acute OM, (c) chronic 
OM, and representative en face images from a commercial video otoscope: (d) normal, (e) acute OM, (f) 
chronic OM. OCT images (a–c) allow for quantitative distinction between infection types. Added lines in (c) 
denote the location of the TM (yellow) and the biofilm (blue). Arrows highlight the extent of biofilm across 
TM. Each scale bar (white) represent 150 microns in depth.  
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Table 1: Summary of imaging subjects, clinical history, and 
corresponding thickness measurement. In the chronic OM 
group, the total thickness is listed first, with the TM only 
thickness, if available, in parenthesis. NA – Not available; ET 
– Eustachian tube. 
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Statistical calculations are displayed in Table 2. The power of each study was 
calculated61, which demonstrates that each infection group is statistically separate from 
other groups, qualitatively indicated by the grouping within the data. Similar calculations 
were performed that show the chronic TM-only is statistically separate from the acute 
case, and statistically similar to the normal group.  
a 
Fig. 11: Analysis of TM thickness between diagnostic groups.  
(a) Histogram of TM thickness between three diagnostic groups. The 
chronic OM group has been subdivided to show the thickness of the 
TM and the thickness of the biofilm. (b) Measured average thickness 
and statistical analysis presented by group. Mean and Standard 
Deviation (error bars) of thickness measurements in microns.    
b 
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The information gained with this technique can assist in the clinical management 
of OM, and provide further insight and understanding into the relationship between 
middle ear infection and biofilm formation. This information is not possible to obtain with 
present clinical methods, which rely mostly on subjective and qualitative diagnostic 
factors.  The overall thickness of the TM and the presence of a biofilm are shown to be 
important indicators of infection, and together are presented here as a new metric to 
diagnose OM.   
The proper analysis of the experimental data is inherently coupled the 
fundamental understanding of the optical scattering properties of tissue. OCT signal is 
dependent on differences in the refractive index of cells and tissue within the TM and 
middle ear, as well as the angle of incidence of the TM during scanning. Features in 
OCT images correspond to the magnitude of the difference of the index of refraction at 
a boundary between tissue types or fluids. Each tissue and fluid also has an associated 
index of refraction, which can change as a result of infection.  
Typically, normal TMs appear thin and have a thickness of approximately  
100 µm, with a relatively strong and uniform scattering signal. This provides a clear 
OCT signal and a relatively uniform image. Acute infections cause the TM to thicken 
Table 2: Statistical results of data. Welch's t-test between groups, p-
values, and power show normal, acute, and chronic groups are 
statistically distinct when classified by thickness. The chronic TM-only 
group is statistically similar to the normal group, and distinct from the 
acute group. 
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when compared to a normal TM, and has a lower scattering signal as a result of 
inflammation, due to the increase in interstitial fluid in the TM. This fluid physically 
separates or dilutes the different scattering components within the tissue. An inflamed, 
erythematous, and injected TM will also contain more optically-absorbing blood 
(hemoglobin), which further reduces the overall signal. When a chronic infection and 
associated biofilm are present, the optical scattering of the TM appears to return to a 
profile similar to the normal case. This may be influenced by the ability of the bacterial 
biofilm to evade the immune response62, which is regularly seen in many biofilm-related 
infections from implanted prosthetics. 
Clearly identifiable biofilms were found in 89% (8/9) of chronic OM infections. It 
should be noted that the 9th case had no visible boundary between the TM and biofilm, 
but had a total thickness comparable to the other chronic OM cases. While the overall 
thickness increased significantly in chronic cases, this was most likely caused by the 
presence of the biofilm, as the TM had largely returned to normal values.  
There are several limitations to the collected data that must be addressed. First, 
the exact location of each scan on the TM was not recorded. However, the majority of 
data was collected near the light reflex, a small cone of light visible on the TM in 
otoscope images. Coincidentally, this region also produced the brightest signal. 
Therefore, the reported thickness measurements should be considered as an average 
from this region of the TM. In this study, the OCT system was limited to cross-sectional 
scans of the TM roughly 2 mm in depth and 2-3 mm in the transverse dimension. While 
this was sufficient for extracting accurate thickness measurements, wider-field 3-D 
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scans of the TM are ideal and will be implemented in the future to fully account for any 
spatial variations across the TM. This imaging capability may be most relevant in some 
early chronic OM cases where biofilm microstructure may be non-uniform or patchy, 
and distributed across the TM and middle ear.  
The results presented here suggest image-based biomarkers are an effective 
tool that can be utilized to help distinguish normal, acute, and chronic OM in pediatric 
subjects. Differentiating infection types through TM thickness may be a worthwhile 
diagnostic metric, as each group shows statistically significant separation from one 
another. Utilizing the presence of a biofilm and the thickness of the TM as part of the 
decision-making process for diagnosing OM could greatly increase the diagnostic 
accuracy of physicians with minimal added exam time.  
This study presents a novel non-invasive method to measure TM thickness  
in vivo, to identify middle-ear biofilms, and collectively, to help differentiate types of OM. 
With the added quantitative image-based diagnostic information provided by the 
handheld imaging system, decisions determining appropriate patient care can be 
supported with more quantitative findings. This device can be envisioned as a tool that 
helps physicians rapidly differentiate different infections patients may present. Using the 
chief complaints and information gained from the patient alongside the quantitative data 
provided by the handheld system, it may be possible to differentiate true cases of OM 
from other upper respiratory tract or Eustachian tube dysfunctions. Similarly, patients 
with recurrent or atypical presentations of OM infection can be investigated more 
thoroughly with this tool, and if necessary, monitored over time. Patients with recurrent 
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or chronic infections, or infections with a positively identified biofilm can be referred to 
specialists earlier for more timely and appropriate care. This technology can provide 
physicians with an objective, quantitative, non-invasive look into the infection state of 
the middle ear by helping to identify the presence or absence of a biofilm and to quantify 
the thickness of the TM.  
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Chapter 4: Quantification of Middle Ear Effusions 
4.1: Introduction and Motivation 
Middle ear effusions (MEEs) are accumulations of fluid within the middle ear 
cavity (MEC), and one of the classic symptoms of acute OM. MEEs form when the 
Eustachian tube’s normal function is altered by constriction due to inflammation or 
physical blockage, both of which prevent drainage from and airflow into the MEC. The 
air remaining inside the MEC continues to be absorbed as normal. Due to the blockage 
in the Eustachian tube, a negative pressure forms and draws fluid from the surrounding 
tissue back into the MEC. Figure 12 illustrates this process. The viscosity, coloration, 
opacity, and turbidity of the fluid are dynamic, depending on the duration and/or cause, 
and can be filled with bacteria, virus, and fungi63, as well as proinflammatory and 
immunoregulatory response cytokines64.  
 
MEEs are traditionally diagnosed alongside acute OM or alone as OM with 
effusion (OME). MEEs are first suspected on visual inspection, alongside evidence 
gathered from the physical exam and patient temperament, any evidence of tugging at 
the ear or neck, or a feeling of fullness or pressure in the MEC. There are several 
Fig. 12: The formation of a MEE. (a) The Eustachian tube first becomes blocked (Red X). (b) 
Subsequently, the air in the MEC is absorbed into surrounding tissue (Red arrows). This 
creates a negative pressure which (c) draws fluid from the surrounding tissue (Blue arrows). 
b c a 
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techniques utilized for assessing the presence of a MEE with varying degrees of 
accuracy. One such method, tympanometry, uses a pure tone of 226 Hz to excite the 
TM. Since the TM stiffens during infection, 226 Hz was chosen to accurately measure 
the stiffness, or compliance, of the TM, rather than mass or friction as when measured 
by other frequencies65. A tympanometer measures the reflected sound returning from 
the TM. Data from this device will indicate when the TM may stiffen during infection, 
causing changes in the amount of sound reflected back to the device. Three classes of 
results are usually obtained, A (normal), B, and C type tympanograms. B and C type 
plots can indicate one of more problems in the MEC, and cannot be used alone to 
differentiate MEE and acute OM in young children66.  
Reflectometry is a method similar to tympanometry, instead using a sweep of 
frequency tones to characterize the TM. Unfortunately, reflectometry is also not clinically 
useful on its own67. MEPA utilizes a wide range of acoustic frequencies to diagnose 
conductive hearing loss in infants and adults, and can be used to identify MEE. It 
functions similarly to reflectometry, but adds additional information based on the 
reflectance, impedance, and admittance of the TM. Ultimately, pneumatic otoscopy is 
considered the gold standard for assessing the presence of a MEE12. Further 
information regarding the accuracy of these methods is briefly described in Chapter 2.   
Effusions can present in many forms, and determine the naming convention for 
OM when diagnosed. Serous effusions are watery and clear, and are formed in similar 
situations as Figure 13, where the Eustachian tube becomes blocked, or in response to 
antibiotic treatment68.  Mucoid effusions are more viscous and turbid than serous 
effusions, due to the significantly higher amounts of mucin69 which is triggered with 
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inflammation of the MEC70. Both serous and mucoid effusions can be diagnosed as 
OME. If significant inflammation is present, or the effusion is purulent, this is better 
characterized as acute OM. 
The turbidity of the effusion plays a significant role in the diagnosis of MEEs. 
Current diagnostic protocols recommend that any MEEs qualitatively considered turbid 
or purulent are assumed to be caused by an infection, and a diagnosis of acute OM is 
likely. While the host immune response does play a small role in increasing the turbidity 
of the MEEs, biofilms significantly increase the purulence of MEEs due to an increased 
production of a capsular polysaccharide71.  Neutrophil extracellular traps, a host 
immune response that attempts to capture and shield the host from further bacterial 
infection, also likely affects the turbidity as well as viscosity of the MEE72.   
Effusions can persist for much longer than is typically expected, and have been 
shown in most cases to resolve spontaneously by three months73. If the effusion 
persists longer than this time, functional tests must be performed to ensure that any 
hearing loss is not detrimental to normal learning, language, hearing capability, and 
functional development in children. Effusions lasting four months or longer most likely 
require surgical intervention, as otherwise damage to the TM and middle ear can occur. 
It is still a topic of debate amongst speech pathologists if adverse delays in speech 
development are detrimental to cognition and similar faculties later in life, or if MEEs 
pose only temporary delays in development74.  
To resolve the effusion, either the Eustachian tubes must be cleared, or a 
drainage port must be inserted in the TM. Access to the Eustachian tubes is limited, but 
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the ear canal allows easy access to the TM. Tympanostomy tube placement surgeries 
are straightforward but require a precisely positioned incision in the TM, avoiding the 
finer bones and structures in the middle ear. After the incision is made, any fluid can be 
removed through aspiration, and the tympanostomy tube is placed. The end result is a 
small plastic or rubberized grommet through the TM that allows air flow and drainage 
from the MEC. As the infection resolves, the TM heals and constricts around the 
incision. In most cases, the grommet will be pushed out naturally due to its asymmetric 
physical shape, but occasionally must be manually removed.  
Identifying and characterizing an effusion is a critical task for physicians for 
determining the proper course of treatment, and provides motivation for the detection 
and quantification of MEEs. This chapter will describe a new algorithm implemented to 
assess the presence of MEEs, and subsequently characterize their biomechanical 
properties.  
4.2: Materials and Methods 
This section will describe the development of computational algorithms that 
identify an effusion and characterize its viscosity. To fully diagnose a MEE, the first goal 
is to identify if an effusion is present. There are several methods that utilize the 
quantitative data that OCT systems can provide to detect moving particles or scatterers 
within an image. By tracking either the intensity or the phase (or both) of the complex 
OCT signal at the same spatial position over time, it is possible to track any time-varying 
changes in the signal. This is more commonly known as speckle and phase variance 
OCT imaging.  
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4.2.1: Computational methods to detect MEEs 
 
Speckle variance OCT and phase variance OCT processing techniques are 
commonly used to detect microvasculature75, or more generally blood flow76,  in 
numerous tissue sites around the body. These methods are similar to Doppler and 
micro-angiography techniques, but rely on time-variant scattering components within the 
body, such as a blood cells passing in and out of the OCT beam, to identify a time 
varying signal. Each technique utilizes the time varying signal of the complex OCT 
signal. Speckle variance OCT uses the intensity of the signal, whereas phase variance 
OCT uses the phase component as the main source of contrast in the processing. 
Phase variance OCT will be utilized in this thesis research, chosen for its greater 
sensitivity to small changes in scattering.  
To clearly demonstrate this technique, a simple example will be discussed. 
Figure 13 depicts a typical single cross-sectional OCT image of a capillary tube filled 
with a flowing and optically-scattering fluid (Intralipid). With standard structural OCT 
imaging, only the scattering structures are visible. It may be possible to infer flow within 
the capillary tube if the signal is dynamically changing, but this assumes prior 
knowledge of the sample of interest, which is usually not available within the MEC.   
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When the composition and structure of the sample is unknown, it is imperative that an 
impartial method be used to accurately detect the presence of liquid. For example, 
using phase variance OCT processing, it is possible to detect and isolate the resulting 
time-varying signal coming from the Brownian motion within the capillary tube, as 
demonstrated in Figure 14. Note that the static or non-varying structural components in 
the image no longer appear as in Figure 13.  
Fig. 13: A cross-sectional OCT image 
of a plastic capillary tube filled with a 
scattering solution of Intralipid and 
water. Unless prior knowledge of the 
sample is known, the liquid cannot be 
positively identified with this image.   
Fig. 14: The resulting phase 
variance signal from only the 
diffusive particles within the 
capillary tube. All non-varying 
structural components produce 
little to no signal.  
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Unfortunately, this method cannot isolate signal from liquids that are non-scattering. 
Figure 15 shows the lack of signal from a capillary tube filled with water.  
 
As briefly demonstrated, phase variance is a useful processing technique for 
OCT that can give contrast in our OCT scans of structures that have a time-varying 
signal, such as diffusing or flowing optically scattering liquids. To perform this 
processing, cross-sectional OCT scans are collected from a single position over time, 
whether using M-mode or B-mode OCT images. Using the complex OCT signal ( ( )), 
the difference in signal between two points in time is determined by: 
(
       
 
)  (     ), 
Then, by taking the circular variance at each point of this difference: 
       | |     
|∑     |
 
, 
Fig. 15: The resulting phase 
variance signal from flowing water. 
Phase variance OCT cannot detect 
non-scattering media.  
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it is possible to determine any time-varying components of the observed signal77,78. 
Figure 16 describes this process qualitatively.  
 
Phase variance processing has certain limitations and requirements needed to 
collect an accurate measurement of the time varying scatterers. Specifically, the phase 
noise of the system will determine the minimum change in phase that can be resolved 
above noise. This is a system dependent characteristic, and can be  calculated79 as:  
     √(
 
      
)  (
  
 
)(   (  (
  
 )
 )) 
Fig 16: Phase variance processing. 
Repeated cross-sectional OCT scans 
are acquired in one location over a 
short time period (left). The phase at 
each location will vary depending on 
the structure observed (bottom). 
Phase changes in solid materials 
exhbit a constant phase, producing a 
large, constant signal. In liquids and 
in air, this phase will vary randomly, 
providing on average a low signal. 
After taking the circular variance, the 
location of liquids can be determined.  
𝑡 
𝑡  ⋯𝑛𝛥𝑡 
Solid 
Liquid 
  Δ𝑡    𝛥𝑡    𝛥𝑡𝑛            ∑𝑅𝑒
𝑖𝛥𝜑
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where SNRs/n is the ratio of the power returning from the sample and the average value 
of the intensity noise floor, Δx is the distance between two A scans, and d is the beam 
diameter.  
4.2.2: Computational methods to quantify MEEs 
Once an effusion is positively identified, the solution of interest can be further 
classified. First, the viscosity of an effusion is known to be highly correlated with the 
incidence of chronic OM80. To characterize the mechanical properties of an effusion, the 
decorrelation time of scatterers within an effusion will be characterized. By observing 
the Brownian motion of particles as they diffuse throughout the effusion, it will be 
possible to relate their behavior to the viscosity of the effusion. In the middle ear, this 
will be a useful technique to verify the effusion type. One limitation to this method is the 
dependence on scattering particles. If no scatterers appear, the effusion may be more 
serous. In this case, the effusion can be diagnosed by visual inspection or pneumatic 
otoscopy. If scatterers are present, they may indicate a bacterial infection beginning to 
proliferate71,72, and can be subsequently identified with this method.  
Quantifying the decorrelation of particles relies on the relationship between the 
Einstein-stokes diffusion constant and the measured signal from a Fourier-domain OCT 
system81. To be valid, this relationship has several assumptions, such as that all 
particles in the solution or suspension are a hard-sphere with a hydrodynamic radius R, 
and that there is no added external energy in the solution, excluding Brownian motion. 
The hydrodynamic radius is defined as the radius of a particle that diffuses at the same 
rate as the particles of interest. The hydrodynamic radius can be larger or smaller than 
the radius of the actual particle of interest, and is an abstraction that helps to account 
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for non-spherical particles in the solution. A solution achieves movement purely from 
Brownian motion when no external energy is applied to the solution, such as mixing or 
currents.  A customized algorithm has been implemented that can recover the diffusion 
constant of a solution. By taking repeated depth-resolved M-mode OCT scans at a 
single spatial position in a solution, then taking the Fourier transform of this data across 
time, a Lorentzian curve82 can be recovered whose linewidth is related to twice the 
diffusion constant times the scattering coefficient: 
                  
       
    
       
   
   
     
 
    (
 
 
) 
where D is the Einstein-Stokes diffusion constant,    is the Boltzmann constant,   is 
viscosity, T is temperature in Kelvin, and r is the hydrodynamic radius83. Figure 17 
describes the processing in more detail. 
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To test and verify this algorithm, a range of five solutions of calibrated viscosity 
were tested. These samples were created by mixing a precise amount of glycerol and 
water, resulting in a known value for viscosity and index of refraction when at room 
temperature84,85. These solutions were then mixed with polystyrene microspheres 
(Bangs Labs, Inc) with an average particle size of 0.53 µm to provide uniform scattering. 
The final suspension of each solution has a microsphere concentration of 10 
  
  
 
   
   
,.  
This suspension was mixed using a standard touch mixer for two to three minutes to 
ensure a well dispersed suspension. 
Fig 17: Typical decorrelation processing. (a) Acquire repeated M-mode scans at one 
particular location. (b) Compute the Fourier transform through time to recover the 
power spectrum, then fit a Lorentzian curve to this peak to find the line width.  
a 
b 
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Each sample was scanned using a custom built spectral-domain OCT system 
that utilized a mode-locked Ti-sapphire (Kapteyn-Murnane Labs, Co) laser as its optical 
source. is the laser output was centered at 800 nm wavelength and had a bandwidth of 
approximately 120 nm, which provided an axial resolution of 1.8 µm and a transverse 
resolution of 16 µm in water. M-mode scans of the samples were acquired at an axial 
scan rate (     ) of approximately 25 kHz. To sufficiently measure the coefficients of 
diffusion in this setting, the sample acquisition has a lower limit81 of: 
     
 
     
   
Results of the repeated experiments with these samples are shown in Figure 18. 
The measured viscosities, taken from the Lorentzian fit, are overlaid as red points on 
the theoretically calculated line width in blue, and plotted against viscosity. The data fits 
well to the expected model of glycerol-based phantoms at room temperature, and 
provides sufficient verification for this method.  
A Japanese study observed the viscosity from nearly two hundred and fifty 
MEEs, which determined the approximate ranges for serous and mucoid effusion 
viscosities86. This range is accessible to this decorrelation technique, with median 
values of 1.2 poise for a serous effusion and 16 poise for a mucoid effusion, which 
corresponds to 2 to 3.2 log10 mPa-S, or 120 to 1600 mPa-S on a linear scale. Figure 19 
shows the expected theoretical response of samples taken from within the MEC. The 
final outcome of this measurement will depend on the characteristics of the effusion, 
specifically the temperature and turbidity, which can vary for each sample.   
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Fig. 18: The relationship between measured line width and 
experimentally measured viscosity (red) for glycerol-based 
samples.  For reference, the theoretically expected line width 
is plotted in blue.  
Fig. 19: In the conditions of the MEC, the expected line width 
versus viscosity is shown in blue. Two points mark the 
median values of serous and mucoid effusions in red.  
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Another quantitative metric that can be investigated to quantify MEEs is the 
attenuation coefficient of the fluid. This behavior is well characterized by the Beer-
Lambert law87, which states that the intensity of a propagating light beam will decrease 
from absorption and scattering when passing through the solution. Well-defined 
methods exist to precisely quantify the attenuation coefficient88. In the upper respiratory 
system, the link between increasing bacterial load in the nasal cavity and worsening 
infection state of the ear has been shown89. Analysis of MEEs90 similarly reveals that 
bacterial load is correlated to the amount of inflammatory cytokines, providing evidence 
that attenuation caused by changes in turbidity could potentially be another currently 
uninvestigated metric for quantification.  
4.3: Results and Discussion 
The detection and quantification algorithms that have been developed will be 
utilized for the investigation of representative OM phantoms. Utilizing a training tool for 
new physicians, it is possible to simulate various states of infection in the middle ear. 
Named “Ear-L”, this training tool includes a removable plastic middle ear insert to 
simulate a middle ear cavity, and sheets of plastic for a simulated TM. To examine the 
efficiency of the detection and quantification algorithms, representative phantoms of 
various middle ear infections were created and scanned to simulate real-world 
encounters of OM. Figure 20 shows the various components in Earl.  
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4.3.1: Middle ear effusion phantoms 
 
In this following section, several phantoms representing typical presentations of 
OM will be analyzed, including a normal TM, a TM with biofilm, and a TM with biofilm 
and an accompanying serous and mucoid effusion. The TM is represented by a thin 
plastic sheet as shown in Figure 20. Biofilm phantoms are created from cured epoxy 
adhesive, and effusions are the previously discussed glycerol-based suspension of 
microbead particles. In a healthy ear, there is no effusion and the TM thickness is 
unchanged. In the following sets of images in this section, a representative cross-
sectional OCT image is shown on the left, and the phase variance signal from that 
image is shown on the right. The OCT image in Figure 21 shows a cross section from a 
typical TM, with no phase variance signal due to the lack of an effusion.    
Fig. 20: “Ear-L”, a training aide for new physicians to increase their 
experience in diagnosing different presentations of OM. The red 
removable inserts simulate a middle ear cavity, and can contain 
fluid to simulate different types of MEEs. The plastic sheets 
simulate a TM, and are held in place by the black band. Biofilm 
phantoms can be affixed to the TM to simulate chronic OM.  
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In late-stage chronic OM cases, the presence of an effusion is sometimes not 
known, but knowledge of the presence or absence of an effusion is essential for the 
determination of subsequent care and diagnosis of acute OM. Depending on the 
duration of the effusion, surgical intervention may be required to resolve the infection. 
With an OCT scan of the MEC, it may be possible to observe a biofilm but not 
determine the presence of an effusion without additional processing. Figures 22-24 
illustrate this dilemma, observing a model of the TM, biofilm, and associated effusion, if 
present. Figure 22 shows a model of chronic OM (TM + Biofilm) without effusion.  
 
Fig. 22: Chronic OM infection model with an identifiable biofilm phantom 
(left). No phase variance signal is evident due to an empty MEC.  
Fig. 21: A Normal ear phantom. The OCT image (left) shows a typical thin 
TM. There is no phase variance signal in the empty MEC model.  
Biofilm 
TM 
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Fig 23: Chronic OM phantom with a serous effusion. Phase variance 
processing clearly identifies the effusion. Decorrelation time for the effusion is 
8 s
-1
 which deviates from the 4.5 s
-1
 expected theoretical value. 
If an effusion is suspected, it can be further identified and characterized with 
phase variance OCT processing and decorrelation techniques. Figures 23 and 24 show 
the location of two effusions from two different chronic OM phantoms, comprising of a 
TM, biofilm, and effusion. Each phantom represents a typical effusion that may present 
to physicians. The effusion in Figures 23 and 24 were determined to have linewidths of 
approximately 8 s-1 and 2.5 s-1, respectively. This deviates from the expected theoretical 
values for these effusion phantoms (4.5 s-1 and 0.9 s-1), but the data still allows for 
discrimination between different effusion types. This may indicate that the samples were 
not accurately mixed, resulting in a different viscosity than expected, or that multiple 
scattering is broadening the power spectrum82. This would suggest that the presence or 
absence of a biofilm, or similarly the thickness of the TM, and even the dispersion and 
scattering properties of the effusion will affect the measured viscosity.  
 
  
  
 
Biofilm 
TM 
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4.3.2: Preliminary in vivo measurements 
 
To begin in vivo verification, a study of a normal ear is shown in Figure 25, which 
utilized the second-generation portable system described in Chapter 5. The phase 
variance signal shows no effusion, as expected. With the added movement from the 
imaging participant and the handheld probe operator, imaging speed, resolution, 
imaging depth, and stability will be the most important factors to monitor for proper data 
collection in this setting. The processing requires scans that are coincident with one 
another. Useful scans must be stable through time and in position. Apart from utilizing a 
faster imaging speed to reduce the stability requirements of the sample, using a 
structural component of the middle ear as a phase reference may alleviate some of the 
phase noise from bulk motion in more unstable datasets. Near a solid-liquid interface, 
the diffusion constant can be altered, affected by hydrodynamic interactions with the 
solid interface91. In this regard, the imaging system must have sufficient imaging depth 
Fig 24: Chronic OM phantom with a mucoid effusion. Phase variance processing 
clearly identifies the effusion, ignoring the air bubble present in the bottom right 
corner of the figure. Decorrelation time for the effusion is 2.5 s
-1
 which deviates 
from the 0.9 s
-1
 expected theoretical value.  
Biofilm 
Air Bubble 
TM 
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to observe any effusion clearly past any potential biofilm to accurately characterize the 
effusion.  
 The success of these algorithms will most likely relate to the stability of the 
handheld probe and the imaging conditions of the effusion. Not only must the patient 
remain stable during imaging, but the effusion must also be under purely diffusive 
conditions and have visible scatterers. This may require the patient to sit still for a more 
significant amount of time than normal, depending on the viscosity of the MEE, to allow 
for particles to return to a baseline state. However, the clinical utility of being able to 
identify and characterize effusions will provide much needed information to physicians, 
and may warrant this extra exam time.  
4.3.3: Changes in attenuation coefficient with turbidity 
The attenuation coefficients of several water and microbead suspensions at 
various concentrations were measured. To eliminate sample to sample variations, data 
was taken sequentially with the handheld probe without modifying any system 
performance parameters. Imaging depth was set near the zero-delay point of the 
system to avoid effects from spectrometer roll-off and the confocal gate. Table 3 shows 
Fig. 25: A normal ear in vivo. There is no phase variance signal due to the empty MEC.  
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the results of this experiment. There is an overall trend that the attenuation coefficient 
decreases in magnitude with decreasing concentration of scattering beads. With further 
study, it may be possible to link turbidity with the concentration of scatterers in an 
effusion, and correlate these characteristics with infection state.  
 
Future work for this technique will focus on differentiating between types of 
middle ear effusions in phantoms and in vivo using both turbidity and viscosity 
measurements. If samples of the MEE fluid can be acquired, the viscosity and turbidity 
of the effusion can be directly measured by other gold-standard methods and compared 
to the experimental OCT-determined values. The ability to determine the difference 
between a serous effusion and a mucoid effusion, through both viscosity and 
attenuation measurements, will provide doctors with additional diagnostic information 
that may help guide treatment. This added information can then be combined with other 
known diagnostic factors, such as the thickness of the TM or the presence of a biofilm, 
to assist the physician in directing further care.   
Table 3: Comparison of bead concentration against attenuation coefficient. 
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Chapter 5: Development of a Second Generation PCI System  
5.1: Introduction 
It has been several years since the construction of the first-generation primary 
care imaging system. It was one of the first systems of its kind to integrate a non-
invasive optical imaging modality into a handheld probe and portable cart. Since then, 
several improvements and advancements to the optical design, handheld probe 
construction, and software layout have been envisioned. To take advantage of these 
technological advances, a second, upgraded, and enhanced system was needed for 
future longitudinal studies. This new system must not only improve the quality of the 
OCT imaging technology that made the first generation system successful, but also 
improve the usability and portability of the system. Special attention was given to retain 
the functionality of the first-generation probe while improving the specifications of the 
OCT subsystem, such as imaging depth, resolution, and imaging speed, as well as 
integrating a full-color CCD camera. In this section, the engineering, development, 
construction, and assembly of this second-generation system will be briefly described.  
5.2: Materials and Methods 
 To begin designing the second-generation system, the components and 
specifications of the first-generation system were tabulated. Improvements and design 
tradeoffs of each were considered, weighing the potential improvements gained against 
additional cost and complexity added. Initial design specifications for the second 
generation system are listed below in Table 4, indicating realistic yet high-end 
performance specifications. 
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System Parameter Acceptable performance 
Spot size 30 µm 
Axial Resolution 5-10 µm 
OCT Imaging speed 20 fps @ 700 A-lines 
CCD resolution 3 MP 
Light source bandwidth Centered 800nm, +/- 40 nm 
Spectrometer camera 
2048 pixels,  
70 kHz 
Spectrometer Resolution 0.05 nm / pixel 
Field of View 2 mm x 2 mm 
Probe output power > 2 mW 
Probe Dimensions DxWxH (cm): 4 x 10 x 15 
Probe Weight  < 500 g 
Cart Dimensions DxWxH (cm): 40 x 50 x 200  
 
The OCT subsystem is a standard Michelson interferometer, integrating custom 
built and commercially available components. A light source (T-860HP, Superlum, Ie) 
that contains 3 separate SLD modules in total provide 135 nm bandwidth at the FWHM 
with 12 mW at the output fiber port. This broad bandwidth directly increases the 
possible axial (depth) resolution of the system. Unfortunately, many other optical 
components, including interferometers, lenses, and patch cables are limited in 
performance over a large bandwidth. For example, most commercially available 2 x 2 
50/50 split ratio couplers perform well only over a 100 nm bandwidth. Fused fiber 
collimators were custom ordered (OZ Optics, CA) to ensure low coupling losses and 
minimized alteration of the spectral shape. A spectrometer that can resolve this broad 
bandwidth but also provide fine spectral resolution was required. The spectrometer is a 
custom fabricated unit (Wasatch Photonics, UT) with a 0.05 nm / pix resolution and a 
high speed line-scan camera (spl4096-140km, Basler, De). The high-resolution 
Table 4: Design specifications for the second-generation Primary 
Care Imaging system. 
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spectrometer will ensure proper spectral sampling at each wavelength and allow for a 
greater imaging depth and higher sensitivity for more efficient use of available SNR.  
The design of the remainder of the system is an exercise in optimized collection 
of light to the spectrometer. Optical elements were chosen with the proper optical 
coatings to limit losses from back reflections and absorption, and the number of fiber 
mating sleeves was optimized to still allow for modularity within the optical system for a 
more simplified repair process.  Labview-based systems are routinely utilized as an 
industry standard and in previous systems in the group. A Labview based operating 
system (National Instruments, TX) with associated DAQ (6353) and IMAQ (1433) cards 
were chosen to have at least 4 analog output ports to interface with and drive the 
MEMS mirror. The MEMS mirror (AdvancedMEMS, CA) is a 3.6 mm diameter, Al-
evaporated coated silicon mirror that requires differential voltage pair inputs, centered 
around 4.667 Volts, to properly drive scanning patterns. Subsequently, this device is 
capable of 300 Hz B-scan rate at resonance. The computer system was chosen to 
contain sufficient PCI connections required for this system, and components with 
sufficient processing speed to utilize CUDA/GPU-based processing within Labview.   
 The physical layout of the handheld probe, the collimator, MEMS, and objective 
lens, while simple, are the building blocks of the entire probe. Special care was taken to 
accurately model the position, size, and specifications of each component. Zemax, 
(RadiantZemax, WA) an industry standard optical engineering design tool that allows 
simulation and testing of optical designs, was utilized to choose, design, and optimize 
the OCT and CCD optical subsystems within the handheld probe.  
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 The optical components chosen for the OCT system were verified on the bench 
top with a simple optical setup. Once this design was confirmed, the design and 
integration of the CCD camera could begin, due to the dependence on the objective 
lens. Ultimately, the CCD optical path was modeled with a single additional lens. Initial 
testing of the CCD path yielded similar successful results. Integration of all the 
components into a handheld probe was performed using Solidworks (Dassault Systems, 
MA), a 3D computer-aided-design (CAD) program. This was instrumental to precisely 
create a robust optical path and integrate all of the optical components into a compact 
form factor more resembling a traditional otoscope. A local 3D printing company (R-cad 
Milling, Il) was contracted to perform 3D printing of the components that allowed for 
inexpensive and rapid prototyping of probe enclosures. The 3D printer is capable of a 
printing resolution of 20 µm droplets, and takes approximately 8 hours per probe 
enclosure to print. After several iterations, the final design precisely aligns the optical 
components, allowing for straightforward optimization and fine adjustment of the optical 
path, as well as secure mounting of all of the components for a robust optical alignment. 
The design and creation of a portable cart followed probe development, which 
integrated all of the main components, including the personal computer, optical source, 
and MEMS driver into a small, more optimized form factor. Results of the system 
development are shown in the following section. 
5.3: Results and Discussion 
 The finalized optical design is shown in Figure 26. This design provides optimal 
delivery and collection of light within the handheld probe, maintaining a tele-centric 
optical system, and providing proper imaging to both OCT and surface video sub-
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systems across the focal plane of the objective. The handheld enclosure houses all of 
the components within a 3D printed casing, providing the capability to adjust the optical 
path if needed while still maintaining a secure and proper alignment. The benefits of 
having a working computerized model enable repairs or future designs to be 
implemented quickly, which is a significant advantage over the previous designs. The 
portable cart was assembled to precise specifications for the internal components, with 
specific focus on portability and ease of use. A touchscreen monitor was implemented 
to allow easier interaction while operating the system, as well as a small tray to hold the 
probe and assorted equipment during transport. The probe’s form factor has been 
greatly reduced, with its size at 3.8 cm x 10 cm x 20 cm, depth x width x height, when 
measuring its largest dimensions. The probe weighs approximately 250 g with the 
cabling sheath attached. The size and weight of the probe are significantly improved 
when compared to the first generation system. The cart is also fairly compact, allowing 
easy transportation to and around local clinics and hospitals, with dimensions of  
35 cm x 62 cm x 150 cm, depth x width x height, if including the adjustable height of the 
monitor. Figure 27 shows the modeled SolidWorks handheld probe enclosure, and in 
Figure 28, the portable cart with attached display screen.   
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Fig 26: Optical layout of probe in Zemax. Figure shows the OCT path (shaded blue) 
overlaid with the CCD camera (red, blue, green lines) path. Inset: SolidWorks model of 
the optical path with associated mounting components for the DM, MEMS, and Col.  
OBJ = Objective lens, DM = Dichroic Mirror, COL = collimator, CL = CCD camera lens.  
OBJ 
DM 
OBJ 
MEMS 
DM 
CL 
CL 
COL 
MEMS 
CCD Detector 
Focal  
Plane 
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Fig. 27: Handheld probe modeled in SolidWorks and the final implemented design, both 
with top cover removed.   
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PC 
MD 
OC 
Fig. 28: Portable cart system modeled in SolidWorks and final implemented design. The front 
compartment is used as storage for the probe during travel, as well as convenient storage of other 
assorted items, such as disposable otoscope attachment tips. The isolation transformer ensures the 
system is protected from both accepting and/or delivering electrical interference from or into the room.  
OC = optics cabinet, SP = spectrometer compartment, MD = MEMS Driver, PC = Computer system,  
SLD = Broadband light source, IT = isolation power transformer.  
IT 
SP 
OC 
MD 
PC 
SLD 
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System performance was characterized and evaluated against the original 
design specifications. Axial and transverse resolution was measured at approximately  
3 µm and 15 µm, respectively. The bandwidth of the spectrometer is fully utilized, filling 
the entire pixel range of the camera. The color CCD performs well, demonstrated by 
imaging a standardized USAF resolution target (Thorlabs R3L3S1P, NJ), as shown in 
Figure 29. Even illumination, properly corrected color balance, and sufficient depth-of-
field remain a challenge for clear and accurate imaging over the large field of view:  
(X x Y: 6.5 mm x 5 mm).  
   
Optimized OCT images are of high quality, having a large dynamic range 
indicated by the low levels background noise. Several representative OCT scans and 
corresponding CCD camera images are shown in the following figures of the ear (Figure 
30), skin, and teeth (Figure 31).    
 
 
 
Fig. 29: Performance of the CCD camera against a 1951 
USAF resolution test chart.  
  
70 
 
 
 
 
 
 
 
 
 
 
Umbo 
Fig. 30: Cross-sectional OCT images of the ear in two distinct locations: (a) near the umbo and  
(b) near the light reflex. The dotted line denotes the location of the scan in each image. Scale bars 
represent 280 µm in depth.  
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The GUI interface of the Labview program is simple and clean, with the main 
focus on the OCT and CCD data. Figure 32 shows a snapshot of the basic layout of the 
Labview GUI.  
Fig. 31: Cross-sectional OCT images of the skin and teeth. (a) Visible sweat ducts in the fingertip, 
denoted with additional arrows. (b) Plaque is visible above the enamel structure. The dotted line 
denotes the location of the scan in each image. Scale bars represent 280 microns in depth. 
Plaque 
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Fast scan speeds afforded by the MEMS and fast OCT processing provided by the 
CUDA-enabled GPU result in a video-rate imaging speed and display (~30 FPS), using 
an integration time of 30 µs with1000 A-lines per image. With 12 bit dynamic range 
(  (     )), the resulting SNR of the system is approximately 105 dB, assuming 
perfect reflectors at the sample arm. The roll-off of the spectrometer is 2.6 dB at 1mm, 
and 5.3 dB at 2 mm.  
This second generation system represents a significant milestone in this project. 
It performs well, capable of imaging in excess of 30 fps with an excellent roll-off, with a 
useable imaging depth of nearly 3 mm. When comparing the current performance to the 
initial design specifications, they have either been met or exceeded. The design and 
implementation of this system represent solutions to significant engineering challenges 
Fig. 32: The Labview GUI interface. OCT data is displayed on the left, CCD images are displayed 
on the right. A cross-sectional OCT image of an injured fingertip is shown on the left, and the 
color CCD image is displayed on the right. Simple controls to collect background scans and 
adjust save parameters are included below the image displays. Scale markers show approximate 
image sizes along each axis.  
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in miniaturization and integration of OCT and video hardware and software processing. 
This developmental work would not have been possible without the collaboration within 
the BIL imaging group and from local and national manufacturing and design companies 
providing robust technologies. Figure 33 shows the completed system.  
 
 
  
Fig 33: The completed second-generation PCI system.  
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Chapter 6: Conclusion and Future Directions  
 This thesis described technical, algorithmic, and design advances for the 
application of OCT in primary care medicine, primarily for screening, detecting, and 
diagnosing OM. One of the most important contributions from these studies is the 
quantification of previously qualitative descriptions of infection in the ear. Current 
diagnostic techniques attempt to qualitatively relate the appearance tissue structures 
and patient signs and symptoms to infection, relying upon the experience of the 
physician for an accurate diagnosis. With the expected increase in patients in primary 
care with implementation of the new healthcare laws soon to be in effect, fast and 
accurate tools that increase the efficiency and accuracy of physicians are desperately 
needed. Significant progress has been made in each goal previously outlined.  
The clinical study of OM has provided new insight into the characteristics of 
different stages of infection. Most notably, all chronic infections appear with a biofilm 
affixed to the TM. This is significant, as the biofilm is not visible behind the TM when 
viewed with a typical otoscope. Another important finding is that the TM itself has 
returned mostly to normal thickness in chronic OM with a biofilm. The main result is that 
normal, acute, and chronic OM infections can be differentiated by the overall thickness 
of the TM. This has important implications for diagnosis and antibiotic prescription, once 
it can be further validated in a larger clinical trial.   
The presence of MEEs during infection has significant implications on the 
treatment of OM, and as such, these need to be positively identified. Algorithms were 
developed and implemented to identify and quantify MEEs. It may be possible to 
differentiate serous and more mucoid effusions based on turbidity and viscosity, which 
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could help physicians better understand the course of infection and help physicians 
provide more appropriate treatment once implemented and tested for in vivo cases. 
Lastly, a second-generation OCT system was redesigned from the basic optical layout 
with improvements across many of its base characteristics. This will provide robust 
measurements in the future in an easy to operate system, and provide a platform for 
future quantitative and longitudinal studies.  
This work has various future directions it can take. The quantification of MEEs 
will be investigated further in vivo to determine clinical utility. Stability of the OCT scans 
may prove difficult to control, but with increased imaging speed, this should become 
manageable. Implementation of a feedback loop that monitors stability of the handheld 
probe using an accelerometer and gyroscope may prove useful in identifying scans that 
are stable. The continued investigation of biofilms is a natural extension to this work, 
especially since little is currently known about their role in infection, or the optical 
properties of biofilms, especially in vivo. A larger clinical study will expand the total 
number of participants to include cases that may fall in between traditional acute or 
chronic diagnoses. It is also possible to longitudinally follow OM throughout the entire 
progression, treatment, and regression of the disease, and perhaps provide a more 
complete understanding of this infection to physicians and medical scientists interested 
in the fundamental infection pathways.   
This thesis represents significant advances towards improving the utility and 
accuracy of medical care through the design, testing, and application of quantitative 
OCT imaging technology.   
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